Lupin Ltd has signed a non-exclusive patent licence agreement with Takeda Pharmaceutical to commercialise Vonoprazan tablets in India. The ...

Alkem Laboratories has entered into a patent licensing agreement with Takeda Pharmaceutical to market Vonoprazan in India. This medication ...

New Delhi: Dr Reddy's Laboratories, a Hyderabad-based firm, and Takeda Pharmaceutical entered a non-exclusive licensing pact to market 10mg...

"With a rich legacy in marketing gastrointestinal therapies in India, we have been offering different breakthrough clinical options across ...

Sun Pharmaceutical Industries announced a licensing deal with Takeda Pharmaceutical to market Vonoprazan, a novel gastrointestinal drug, in...

Takeda Pharmaceuticals' dengue vaccine assumes significance since the first vaccine ever licensed for dengue, developed by French drugmaker...

Vishwachand Kolla, a data analyst at the Takeda Pharmaceutical Company and an Indian-American, died in a fatal bus accident at Boston's Log...

India is not a part of the global Phase-3 trial of the Takeda dengue vaccine candidate, which means as per local regulation it will have to...

Takeda, one of the world's biggest pharmaceutical companies, is not developing its own vaccine but has contracts with several firms to dist...

Cadila Healthcare said terms of the agreement are not disclosed, but it is expected that this partnership will boost access to medicines in...

The product is therapeutic equivalent to the reference listed drug Uloric tablets, 40 mg, 80 mg of Takeda Pharmaceuticals USA Inc, it added.

Rashmi Barbhaiya, who co-founded Tata group-promoted pharmaceutical research company Advinus Therapeutics, has stepped down from the post o...

Dr Reddy’s Laboratories were down on profit booking in early trade after Sucampo Pharmaceuticals and others filed patent infringement lawsu...

Sun Pharmaceutical Industries filed Abbreviated New Drug Applications for 4 products & received 9 approvals from USFDA in Q1 this fiscal.

Sun Pharmaceutical Industries today said its arm Caraco Pharma will buy Japanese drug maker Takeda Pharmaceuticals' US-based generics subsi...

Shares of drug firms Cipla and Lupin surged after news reports surfaced that Takeda Pharmaceutical Co, is in talks to buy either of their p...

Japan's Takeda Pharmaceutical Co has agreed to pay about $8.8 billion for US biotech company Millennium Pharmaceuticals Inc, the two firms ...